Company page

Alterity Therapeutics Ltd.

Alterity Therapeutics Ltd. is a public company listed on the Australian market under the ticker ATH. The company has a market capitalization of approximately AUD 89.2 million. Alterity focuses on developing therapies for neurodegenerative diseases.

profileATH:ASXAI content: aiUpdated June 24, 2026/company/alterity-therapeutics-ltd/c-vgzlforh
Alterity Therapeutics Ltd. logo
Ticker
ATH:ASX
Asset type
Stock
Market cap
$89.2M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
ASX
Currency
AUD